Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDarioHealth Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q3 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q2 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
DarioHealth Corp. Earnings Date And Information
DarioHealth Corp. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.05. The company had revenue of 7.42 M for the quarter and had revenue of 20.35 M for the year. DarioHealth Corp. has generated $-2 earnings per share over the last year ($-1.93 diluted earnings per share) and currently has a price-to-earnings ratio of -0.81. DarioHealth Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
DarioHealth Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.18 | $0.36 | 0.54 | $7.40 M | $7.42 M |
| 08/08/2024 | Q2 2024 | -$0.29 | -$0.08 | 0.21 | $7.92 M | $6.26 M |
| 05/15/2024 | Q1 2024 | -$0.59 | -$0.20 | 0.39 | $5.76 M | |
| 03/28/2024 | Q4 2023 | -$0.44 | $3.62 M | |||
| 11/02/2023 | Q3 2023 | -$0.50 | $0.59 | 1.09 | $5.42 M | $3.52 M |
| 08/10/2023 | Q2 2023 | -$0.52 | -$0.59 | -0.07 | $6.50 M | $6.15 M |
| 05/11/2023 | Q1 2023 | -$0.46 | $0.45 | 0.91 | $7.07 M | |
| 03/09/2023 | Q4 2022 | -$0.60 | -$0.49 | 0.11 | $6.81 M | |
| 11/14/2022 | Q3 2022 | -$0.83 | -$0.73 | 0.1 | $6.29 M | $6.61 M |
| 08/15/2022 | Q2 2022 | -$0.77 | -$0.80 | -0.03 | $8.25 M | $6.18 M |
| 05/11/2022 | Q1 2022 | -$0.98 | -$0.81 | 0.17 | $8.06 M | |
| 03/21/2022 | Q4 2021 | -$1.13 | -$1.38 | -0.25 | $6.03 M | |
| 11/15/2021 | Q3 2021 | -$0.95 | -$1.36 | -0.41 | $5.77 M | $5.63 M |
| 08/16/2021 | Q2 2021 | -$0.84 | -$1.13 | -0.29 | $5.14 M | $5.26 M |
| 05/17/2021 | Q1 2021 | -$0.93 | -$1.07 | -0.14 | $3.60 M | |
| 03/08/2021 | Q4 2020 | -$0.62 | -$1.23 | -0.61 | $2.08 M | |
| 11/12/2020 | Q3 2020 | -$0.84 | -$0.89 | -0.05 | $1.95 M | $2.04 M |
| 08/11/2020 | Q2 2020 | -$1.54 | -$0.97 | 0.57 | $1.56 M | $1.79 M |
| 05/11/2020 | Q1 2020 | -$0.75 | -$3.20 | -2.45 | $1.67 M | |
| 03/16/2020 | Q4 2019 | -$1.02 | -$1.35 | -0.33 | $1.80 M |
DarioHealth Corp. Earnings: FAQ's
When is DarioHealth Corp.'s earnings date?
DarioHealth Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
Did DarioHealth Corp. beat their earnings estimates last
quarter?
In the previous quarter, DarioHealth Corp. (:DRIO) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.05.
How can I listen to DarioHealth Corp.'s earnings conference
call?
The conference call for DarioHealth Corp.'s latest earnings report can be listened to online.
How can I read DarioHealth Corp.'s conference call transcript?
The conference call transcript for DarioHealth Corp.'s latest earnings report can be read online.
How much revenue does DarioHealth Corp. generate each year?
DarioHealth Corp. (:DRIO) has a recorded annual revenue of $20.35 M.
How much profit does DarioHealth Corp. generate each year?
DarioHealth Corp. (:DRIO) has a recorded net income of $20.35 M. DarioHealth Corp. has generated $-1.93 earnings per share over the last four quarters.
What is DarioHealth Corp.'s price-to-earnings ratio?
DarioHealth Corp. (:DRIO) has a price-to-earnings ratio of -0.81 and price/earnings-to-growth ratio is 0.